SCHEMBL22928167

SCHEMBL22928167

CC(C)(C)OC(=O)N1CC=C(c2ccc3[nH]nnc3c2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.41
▸ CDK7 P50613 1/20 0.40
▸ CDK13 Q14004 1/20 0.40
▸ CDK12 Q9NYV4 1/20 0.40
▸ GRM1 Q13255 9/20 0.39
▸ GRM5 P41594 8/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ TBK1 Q9UHD2 1/20 0.39
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ GABRA4 P48169 1/20 0.39
▸ GABRE P78334 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31110485 0.90 NAMPT (0.52) NAMPTCDK7CDK13CDK12GRM1
SCHEMBL22619239 0.80 PDK4 (0.43) NAMPTCDK7CDK13CDK12GRM1
SCHEMBL22619097 0.79 RIPK2 (0.42) NAMPTPDK4TBK1GABRPGABRD
SCHEMBL22619202 0.79 PIK3CD (0.43) NAMPTCDK7CDK13CDK12PDK4
SCHEMBL21210257 0.77 GPR119 (0.47) NAMPTGRM1GRM5PDK4JAK1
SCHEMBL21767846 0.77 NAMPT (0.52) NAMPTGRM1GRM5PDK4
SCHEMBL24607774 0.76 PGR (0.42) NAMPTCDK7CDK13CDK12GRM1
SCHEMBL29751413 0.76 PGR (0.42) NAMPTCDK7CDK13CDK12GRM1
SCHEMBL27025908 0.75 NAMPT (0.47) NAMPTCDK7CDK13CDK12GRM1
SCHEMBL31749310 0.75 NAMPT (0.40) NAMPTGRM1GRM5PDK4TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 NAMPT 3605/4885CDK7 1480/4885CDK13 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback